Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis (Q37951798)

25 August 2017

Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis (English)

1 reference

25 August 2017

0 references

11

1 reference

25 August 2017

Alberto Ortiz

1

0 references

Adrian Covic

7

object named as

Adrian Covic

1 reference

25 August 2017

Bengt Lindholm

4

0 references

Andrzej Więcek

5

object named as

Andrzej Wiecek

1 reference

25 August 2017

2

Ziad A Massy

1 reference

25 August 2017

9

Gültekin Süleymanlar

1 reference

25 August 2017

Danilo Fliser

3

1 reference

25 August 2017

Alberto Martínez-Castelao

6

1 reference

25 August 2017

David Goldsmith

8

1 reference

25 August 2017

Gérard M London

10

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

Nature Reviews Nephrology

25 August 2017

1 reference

25 August 2017

8

1 reference

25 August 2017

3

1 reference

25 August 2017

141-150

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2011.170

25 August 2017

0 references

cites work

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Use and misuse of the receiver operating characteristic curve in risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Do we need to adjudicate major clinical events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Testing for causality and prognosis: etiological and prognostic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Novel Risk Markers and Clinical Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

APACHE—acute physiology and chronic health evaluation: a physiologically based classification system

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

21 January 2018

12 December 2020

C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Public health impact of statin prescribing strategies based on JUPITER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Plasma osteoprotegerin is associated with mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Circulating fetuin-A predicts early mortality in chronic hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Fetuin-mineral complex reflects extraosseous calcification stress in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Use of cardiac biomarkers in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Standardisation of cardiac troponin I measurement: past and present

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Are multiple biomarker testing strategies ready for prime time in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

B-type natriuretic peptides: looking to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Low triiodothyronine: a new facet of inflammation in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Multiple biomarkers for the prediction of first major cardiovascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Prognostic value of biomarkers in heart failure: application of novel methods in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Novel and conventional biomarkers for prediction of incident cardiovascular events in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Inflammation and Asymmetric Dimethylarginine for Predicting Death and Cardiovascular Events in ESRD Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Diagnostic potential of urine proteome: a broken mirror of renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Advances in urinary proteome analysis and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Proteomics: a novel tool to unravel the patho-physiology of uraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Effects of oral vitamin C supplementation in hemodialysis patients: a proteomic assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Comparative proteomic analysis of rat aorta in a subtotal nephrectomy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Practical points in urinary proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Dissecting Inflammation in ESRD: Do Cytokines and C-Reactive Protein Have a Complementary Prognostic Value for Mortality in Dialysis Patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Low triiodothyronine and survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Influence of coexisting disease on survival on renal-replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Accelerated atherosclerosis in prolonged maintenance hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Arterial accelerated aging in dialysis patients: the clinical impact of vascular calcification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Chapter 1: Introduction and definition of CKD–MBD and the development of the guideline statements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients no additional power for mortality prediction with high-sensitivity CRP

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor- are similarly associated with survival in haemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Association of serum fetuin-A levels with mortality in dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Cardiac troponins: outcome predictors in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Proteomic Analysis of Early Left Ventricular Hypertrophy Secondary to Hypertension: Modulation by Antihypertensive Therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.170

Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.

31 March 2020

1 reference

12 December 2020

Serum alkaline phosphatase and mortality in hemodialysis patients.

1 reference

12 December 2020

Primary and subsequent coronary risk appraisal: new results from the Framingham study.

1 reference

12 December 2020

Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2011.170

1 reference

25 August 2017

1 reference